Navigation Links
New research identifies modifiable risk factors for heart disease
Date:12/11/2009

ning the data to include recurrent cardiovascular events during the two-year follow up, authors found additional events were reduced by 19 percent with atorvastatin 80 mg versus pravastatin 40 mg (n = 275 vs. n = 340, respectively; p = 0.009), resulting in 138 fewer total primary events during follow-up. Based on this reanalysis which considers total events, the authors calculate that 14 patients need to be treated to prevent one eventa much smaller number than the 26 needed-to-treat to prevent the first occurrence of the primary end point.

A post-hoc analysis of the IDEAL trial provides new insights into the treatment of patients experiencing repeated occurrences of cardiovascular disease, and shows that high-dose statin therapy remains highly effective. In fact, compared with patients taking simvastatin 20 to 40 mg daily, patients receiving atorvastatin 80 mg daily had their relative risk of a first cardiovascular event reduced by 17 percent (p < 0.0001), of a second by 24 percent (p < 0.0001), of a third by 19 percent (p = 0.035), of a fourth by 24 percent (p = 0.058), and of a fifth by 28 percent (p = 0.117). There was a 17 percent overall reduction in risk across all five events.


'/>"/>

Contact: Amanda Jekowsky
ajekowsk@acc.org
202-375-6645
American College of Cardiology
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
5. New research shows how chronic stress worsens neurodegenerative disease course
6. New research explores newborn in-hospital weight loss
7. Research may unlock mystery of autisms origin in the brain
8. Bipolar disorder relapses halved by Melbourne researchers
9. HIVs impact in Zimbabwe explored in new research
10. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
11. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , ... June 29, 2015 , ... ... C. Cook, to its multidisciplinary group of physicians and specialists. Dr. Cook is ... provide quality healthcare in hopes of achieving outstanding medical outcomes. , “We are ...
(Date:6/29/2015)... ... 29, 2015 , ... Lake Balboa Care Center announced today ... prestigious five-star, premium rating from Medicare. Medicare’s ratings are based on three criteria, ... indicative of its commitment to providing patients with a safe, clean, and comfortable ...
(Date:6/29/2015)... ... June 29, 2015 , ... Human Factors and ... July 16, 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/humanfactors ... factors engineering to the design of new products as well as to postmarket ...
(Date:6/29/2015)... ... June 29, 2015 , ... With Urgent Care Medicine now serving a vital ... Board of Urgent Care Medicine and the Medical Society of Delaware to provide its ... physicians and health care professionals. , According to Matthew Bader, Exam Master CEO and ...
(Date:6/29/2015)... ... June 29, 2015 , ... The world’s fastest and highest ... Museum to the Science Museum of Virginia. This iconic, supersonic stealth plane will become ... “Suspending a supersonic jet from the ceiling of a historic train station is perhaps ...
Breaking Medicine News(10 mins):Health News:Healthpointe in La Tijera Proudly Announces the Addition of a New Chiropractor 2Health News:Healthpointe in La Tijera Proudly Announces the Addition of a New Chiropractor 3Health News:Lake Balboa Releases New Facility Video of Patient Testimonials 2Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 2Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 3Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 2Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 3Health News:SR-71 Prepares for Flight to Science Museum of Virginia 2
... mammograms are more likely to interpret a benign growth ... and experience," and CAD systems do not help detect ... systems use complex algorithms to identify "suspicious" areas of ... which cost $50,000 to $175,000, were approved by FDA ...
... were the biggest killers. Now it appears that the ravage ... the fatalities caused by road accidents. , ... of Edinburgh, has provided statistics which demonstrates the increase in ... in contrast, MRSA cases had dropped by 4.3 per cent. ...
... University, has found a mutation in a single gene that ... among dog breeds and probably is important in determining the ... the April 6 issue of the journal Science, "is one ... dog breeds that share the same trait (such as large ...
... nations is undermining essential health services, including treatments for ... Margaret Chan said on Tuesday in Singapore ahead of ... of health care professionals have left their homes in ... wealthier countries, Reuters reports. ,According to WHO's ...
... African nation and very poor, has banned the life-threatening practice ... ,Anybody involved in female genital mutilation (FGM) would ... ,The move follows a campaign against the practice ... than 90% of Eritrean women are circumcised. ...
... and routine walks could ease uncomfortable symptoms and help women ... ,Menopause is the time in a woman's life when ... occurs naturally, most often after age 45. ... the health of more than 160 women, dividing them into ...
Cached Medicine News:Health News:Researchers Identify Gene That Plays Key Role in Size of Dogs -- and Probably in Humans 2Health News:Eritrea Bans Female Circumcision 2
(Date:6/29/2015)... SAN FRANCISCO , June 29, ... company,s novel blood-draw technology has received CE Mark ... quality from the European Union. This regulatory milestone ... alternative to one of the most common procedures ... Velano Vascular,s proprietary device reduces the ...
(Date:6/29/2015)... , June 29, 2015 ... and predicted revenues ,Where is the market for dermatological ... market? Visiongain ,s new report shows you potential ... and prospects. Our 310 page report ... most lucrative areas in the industry and the future ...
(Date:6/29/2015)... Calif. , June 29, 2015  The ... innovative features to cars on the basis of ... The industry is now on the verge of ... cars. While automotive HWW non-critical features such as ... be present in 30 to 40 percent of ...
Breaking Medicine Technology:Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 3Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 4Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 5Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 6Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 7Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 8Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4
... Expected in November 2008, BOTHELL, Wash., Oct. 9 ... the completion of patient enrollment and dosing,for the third ... and,efficacy of its formulation of 12-hour extended-release (ER) ibuprofen ... top-line,results from this pivotal trial in November 2008. Ibuprofen ...
... Will Reduce Animal Use in Cosmetics and Chemicals ... Corp. today announced,that results of a recently completed ... EpiDerm in vitro human skin tissue,equivalent. The test ... to be accepted as a validated alternative to ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2
... A concentrated enzymatic cleanser ... semi-automated hematology instruments. It ... all Abbott CELL-DYN® hematology ... instruments. The shelf life ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products: